Clinical Trials Browser

Phase 2 × Lymphoma, Non-Hodgkin × tocilizumab × Clear all

Lymphoma, Non-Hodgkin

NCT03434730 2025-04-22

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Clinical Trials

MorningSun

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation